1.

Record Nr.

UNINA9910782042703321

Titolo

Assessment of the scientific information for the Radiation Exposure Screening and Education Program [[electronic resource] /] / Committee to Assess the Scientific Information for the Radiation Exposure Screening and Education Program, Board on Radiation Effects Research, Division on Earth and Life Studies

Pubbl/distr/stampa

Washington, D.C., : National Academies Press, 2005

ISBN

0-309-16514-8

1-280-74214-3

9786610742141

0-309-54931-0

Descrizione fisica

1 online resource (429 p.)

Disciplina

363.1799

Soggetti

Nuclear weapons - United States - Testing

Radiation dosimetry

Radiation - Physiological effect - Research - United States

Radiation - Safety measures

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references.

Nota di contenuto

""Front Matter""; ""Acknowledgments""; ""Reviewers""; ""A Note on the Units of Measurement Used in this Report""; ""Contents""; ""Executive Summary""; ""1 Introduction""; ""2 Legislation and Compensation""; ""3 Basic Concepts in Radiation Physics, Biology, and Epidemiology""; ""4 Review of Recent Data on Radiation Epidemiology, Biology, and Dosimetry""; ""5 Expanding RECA Eligibility: Scientific Issues""; ""6 Expanding RECA Eligibility: Implementation""; ""7 Diseases, Populations, and Other Issues of Public Concern""; ""8 Ethical Framework""; ""9 Medical Screening""

""10 Screening for Compensation""""11 Education and Outreach""; ""References""; ""Appendixes""; ""Appendix A Invited Speakers and Public Comment""; ""Appendix B A Comparison of the Risk of Skin Cancer with the Risk of Lung Cancer from Exposure to Radon Decay Products in Underground Mines""; ""Appendix C Radioactivity in Guam



After Nuclear- Weapons Testing in the Pacific""; ""Appendix D The Optimal Criterion for Positivity in Screening""; ""Appendix E Selected Cancer-Screening Recommendations""; ""Glossary""; ""List of Abbreviations""; ""Committee and Staff Biographies""

2.

Record Nr.

UNINA9910253921503321

Titolo

Behavioral Neuroscience of Orexin/Hypocretin / / edited by Andrew J Lawrence, Luis de Lecea

Pubbl/distr/stampa

Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017

ISBN

3-319-57535-X

Edizione

[1st ed. 2017.]

Descrizione fisica

1 online resource (VIII, 322 p. 30 illus., 22 illus. in color.)

Collana

Current Topics in Behavioral Neurosciences, , 1866-3370 ; ; 33

Disciplina

612.405

Soggetti

Neurosciences

Pharmacology

Psychopharmacology

Behavioral sciences

Neurology

Pain medicine

Pharmacology/Toxicology

Behavioral Sciences

Pain Medicine

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Nota di bibliografia

Includes bibliographical references at the end of each chapters.

Nota di contenuto

The Human Orexin/Hypocretin Receptor Crystal Structures -- Orexin/Hypocretin Signaling -- Orexin/Hypocretin and Organizing Principles for a Diversity of Wake-Promoting Neurons in the Brain -- The Hypocretin/Orexin Neuronal Networks in Zebrafish -- Hypocretins and Arousal -- Orexin OX 2 Receptor Antagonists as Sleep Aids -- Roles for Orexin/Hypocretin in the Control of Energy Balance and Metabolism -- Orexin and Central Modulation of Cardiovascular and Respiratory Function -- Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders -- The Role of



Orexins/Hypocretins in Alcohol Use and Abuse -- A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?- Hypocretin/Orexin and Plastic Adaptations Associated with Drug Abuse.

Sommario/riassunto

This issue of Current Topics in Behavioral Neuroscience focuses on the neuropeptide orexin (hypocretin) and brings together scientists from around the world who will provide a timely discussion of how this peptide regulates behavior. This is a fast-moving field, and with the incorporation of novel technologies, new breakthroughs are likely to continue. For example, the use of optogenetic approaches has enabled the identification of the role of orexin-containing neurons in arousal states, critical for higher order functioning. From a clinical perspective, genetic polymorphisms in hypocretin/orexin and orexin receptors are implicated in a number of psychiatric disorders. In addition, advanced clinical trials are currently underway for orexin receptor antagonists in the treatment of insomnia and sleep disorders. We aim to capture a broad audience of basic scientists and clinicians.